4//SEC Filing
NAVIDEA BIOPHARMACEUTICALS, INC. 4
Accession 0001225208-14-001424
CIK 0000810509operating
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:06 PM ET
Size
8.7 KB
Accession
0001225208-14-001424
Insider Transaction Report
Form 4
LARSON BRENT L
VP Finance and CFO
Transactions
- Exercise/Conversion
Common Stock
2014-01-07$0.30/sh+70,000$21,000→ 357,304 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-01-07−70,000→ 0 totalExercise: $0.30Exp: 2014-01-07→ Common Stock (70,000 underlying) - Tax Payment
Common Stock
2014-01-07$1.93/sh−34,308$66,214→ 322,996 total
Holdings
- 93,217(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Shares withheld by the issuer in payment of the option exercise price and to satisfy tax withholding obligations.
- [F2]Option vests 1/3 of the underlying shares annually beginning on the first anniversary of the date of grant.
Documents
Issuer
NAVIDEA BIOPHARMACEUTICALS, INC.
CIK 0000810509
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000810509
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 4:06 PM ET
- Size
- 8.7 KB